The US Food and Drug Administration (FDA) has tagged a recall of breathing circuits manufactured by Sentec/Percussionaire as ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The Food and Drug Administration has reclassified ... In the Jan. 29 weekly enforcement report, the FDA classified the recall of eight Cal Yee Farm products as a "Class I" designation.
FDA announces recall affecting millions of Dunkin' baked goods including beloved Munchkins, donuts, and fritters - here's ...
The FDA recalled 60 doughnut products, totaling more than 2 million cases, for potential listeria contamination. The ...
Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The Associated Press on MSN11d
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternativeThe medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results